148 related articles for article (PubMed ID: 29276912)
1. [Antihypertensive Efficacy of Fixed Combination Azilsartan Medoxomil / Chlorthalidone in Patients With Uncontrolled Arterial Hypertension].
Kobalava ZD; Villevalde SV; Kulakov VV
Kardiologiia; 2017 Nov; 57(11):12-18. PubMed ID: 29276912
[TBL] [Abstract][Full Text] [Related]
2. Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive.
Pierini D; Anderson KV
Ann Pharmacother; 2013 May; 47(5):694-703. PubMed ID: 23585646
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
[TBL] [Abstract][Full Text] [Related]
4. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.
Cushman WC; Bakris GL; White WB; Weber MA; Sica D; Roberts A; Lloyd E; Kupfer S
Hypertension; 2012 Aug; 60(2):310-8. PubMed ID: 22710649
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone.
Weber MA; Sever P; Juhasz A; Roberts A; Cao C
J Renin Angiotensin Aldosterone Syst; 2018; 19(3):1470320318795000. PubMed ID: 30175930
[TBL] [Abstract][Full Text] [Related]
6. Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.
Neutel JM; Cushman WC; Lloyd E; Barger B; Handley A
J Clin Hypertens (Greenwich); 2017 Sep; 19(9):874-883. PubMed ID: 28681550
[TBL] [Abstract][Full Text] [Related]
7. Azilsartan and Chlorthalidone-new Powerful Fixed dose Antihypertensive Combination.
Katsi V; Athanasiadi E; Tsioufis C; Tousoulis D
Curr Hypertens Rev; 2018; 14(1):15-20. PubMed ID: 29683095
[TBL] [Abstract][Full Text] [Related]
8. Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
Barrios V; Escobar C
Expert Opin Pharmacother; 2013 Nov; 14(16):2249-61. PubMed ID: 24070321
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of azilsartan-chlorthalidone fixed combination in the management of hypertension.
Shuster JE; Bleske BE; Dorsch MP
Vasc Health Risk Manag; 2012; 8():381-7. PubMed ID: 22745562
[TBL] [Abstract][Full Text] [Related]
10. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension.
Baker WL; White WB
Ann Pharmacother; 2011 Dec; 45(12):1506-15. PubMed ID: 22116996
[TBL] [Abstract][Full Text] [Related]
11. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
White WB; Weber MA; Sica D; Bakris GL; Perez A; Cao C; Kupfer S
Hypertension; 2011 Mar; 57(3):413-20. PubMed ID: 21282560
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertension.
Kipnes MS; Handley A; Lloyd E; Barger B; Roberts A
J Clin Hypertens (Greenwich); 2015 Mar; 17(3):183-92. PubMed ID: 25619410
[TBL] [Abstract][Full Text] [Related]
13. Azilsartan medoxomil: a review of its use in hypertension.
Perry CM
Clin Drug Investig; 2012 Sep; 32(9):621-39. PubMed ID: 22877322
[TBL] [Abstract][Full Text] [Related]
14. Azilsartan medoxomil for the treatment of hypertension.
Vasiliou S
Drugs Today (Barc); 2011 Sep; 47(9):647-51. PubMed ID: 21971539
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review.
Katsi V; Michalakeas C; Soulaidopoulos S; Antonopoulos AS; Vlachopoulos C; Tousoulis D; Tsioufis K
Curr Hypertens Rev; 2021; 17(3):217-227. PubMed ID: 33438552
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial.
Collier DJ; Juhasz A; Agabiti-Rosei E; Lloyd E; Hisada M; Zhao L; Kupfer S; Caulfield MJ
J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1473-1484. PubMed ID: 30302936
[TBL] [Abstract][Full Text] [Related]
17. An international multicenter observational non-interventional prospective study of the efficacy of azilsartan medoxomil in overweight or obese patients with arterial hypertension (CONSTANT).
Chazova IE; Zhernakova YV
Curr Med Res Opin; 2021 Feb; 37(2):185-193. PubMed ID: 33119420
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.
Sica D; Bakris GL; White WB; Weber MA; Cushman WC; Huang P; Roberts A; Kupfer S
J Clin Hypertens (Greenwich); 2012 May; 14(5):284-92. PubMed ID: 22533654
[TBL] [Abstract][Full Text] [Related]
19. [Hronotherapy Aspects of Efficiency Azilsartan Medoxomil in Combination Therapy in Patients With Hypertension and Metabolic Syndrome].
Skibitskiy VV; Fendrikova AV; Sirotenko DV; Skibitskiy AV
Kardiologiia; 2016 Oct; 56(10):35-40. PubMed ID: 28290893
[TBL] [Abstract][Full Text] [Related]
20. [Azilsartan Medoxomil Capabilities in Arterial Hypertension and Obesity].
Vasyuk YA; Shupenina EY; Nesvetov VV; Nesterova EA; Golubkova EI
Kardiologiia; 2016 Dec; 56(11):108-112. PubMed ID: 28290827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
